Immortal.life Signals · Global trial geography

Where active longevity trials are being registered

A source-linked map of active and recruiting longevity trial registrations, their countries, phases, sponsors and planned enrolment.

Signal 01

Where is active longevity-related clinical research visible—and how mature is it?

675 active or recruiting registrations are currently visible in the index. The map shows 675 retrieved registrations across 76 country labels; planned enrolment is not completed participation.

Data snapshotOctober 4, 2026Figures update with the connected index
675active registrationsRecruiting, active or enrolling76country labelsAt least one visible registration3,840,036planned enrolmentNot completed participation477named sponsorsRegistry-supplied identities
The geography

Activity is global—but not evenly distributed.

Each bubble represents active registrations that name that country. Multinational studies can appear in more than one country.

233United States75China52Spain50France50United Kingdom40Italy32Canada30Turkey (Türkiye)24Germany23Australia22Taiwan19Hong Kong17Denmark15England15Switzerland14Singapore12Belgium11Austria11Poland11Portugal10Brazil9Hungary8Czechia8Egypt
Country visibility

Where registrations appear

United States233China75Spain52France50United Kingdom50Italy40Canada32Turkey (Türkiye)30Germany24Australia23
Sponsor visibility

Who appears most often

The University of Hong Kong8Fundacion Miguel Servet7Mayo Clinic7National Cancer Institute (NCI)6Assistance Publique - Hôpitaux de Paris6University of California, San Francisco6VA Office of Research and Development6Peking University People's Hospital5
Clinical maturity

Which phases are represented?

Phase labels describe registry design. They do not establish that a study succeeded or that an intervention is safe.

514Not reported87PHASE244PHASE136PHASE312PHASE49EARLY PHASE1
Open the evidence

Registrations behind the picture

  1. NCT07856381Understanding Lifespan Trajectories of Social Cognition, Brain Microstructure and Iron Dysregulation in SchizophreniaMedical University Innsbruck · 180 planned
  2. NCT05463133Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Granulomatous Disease (CGD) With an Alemtuzumab, Busulfan and TBI-based Conditioning Regimen Combined With Cytokine (IL-6, +/- IFN-gamma) AntagonistsNational Institute of Allergy and Infectious Diseases (NIAID) · 50 planned
  3. NCT04853251A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age-related Macular Degeneration (nAMD) Treated With the Port Delivery System With Ranibizumab (PDS)Genentech, Inc. · 188 planned
  4. NCT06073106Targeting Osteosarcopaenia and Multimorbidity for Frailty PreventionTan Tock Seng Hospital · 500 planned
  5. NCT07355413Frailty, Geriatric Syndromes and Care Pathways of Older Adults Living With HIV in West AfricaANRS, Emerging Infectious Diseases · 600 planned
Explore every active registration →
For journalists and researchers

Use the figure. Check the records.

Suggested citation: immortal.life Signals, “Where active longevity trials are being registered,” data accessed October 4, 2026.

Open filtered trials →Download trial data →Read the methodology →Ask about the data →